As the pharmaceutical industry inches closer to (hopefully) producing a safe and effective vaccine for the novel coronavirus, everything from the science of the inoculation to how to distribute vaccines that may require cold storage remains in doubt.
But it’s one thing to develop a vaccine and plot how you get it out to the masses, and quite another to actually manufacture doses by the millions. That’s especially true of the leading vaccines from Pfizer and Moderna, both of which rely on cutting-edge messenger-RNA technology.
Welcome to Rabbit Hole, where we dive deep on the biggest story. It’s for Beast Inside members only. Join up today.